Phase II trial of toremifene in androgen-independent prostate cancer a penn cancer clinical trials Group trialSTEIN, Steven; ZOLTICK, Barbara; PEACOCK, Thomas et al.American journal of clinical oncology. 2001, Vol 24, Num 3, pp 283-285, issn 0277-3732Article

HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast CancerPRESS, Michael F; FINN, Richard S; DANENBERG, Kathy et al.Clinical cancer research (Print). 2008, Vol 14, Num 23, pp 7861-7870, issn 1078-0432, 10 p.Article

Lapatinib plus capecitabine for HER2-positive advanced breast cancerGEYER, Charles E; FORSTER, John; SKARLOS, Dimosthenis et al.The New England journal of medicine. 2006, Vol 355, Num 26, pp 2733-2743, issn 0028-4793, 11 p.Article

Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropeniaROSENBERG, Philip S; ALTER, Blanche P; NEWBURGER, Peter E et al.British journal of haematology. 2008, Vol 140, Num 2, pp 210-213, issn 0007-1048, 4 p.Article

Polymorphisms in inflammatory cytokines and Fcγ receptors in childhood chronic immune thrombocytopenic purpura : a pilot studyFOSTER, Charles B; SHAOXIAN ZHU; KÜHNE, Thomas et al.British journal of haematology. 2001, Vol 113, Num 3, pp 596-599, issn 0007-1048Article

4(1H)-Quinolones with Liver Stage Activity against Plasmodium bergheiLACRUE, Alexis N; SAENZ, Fabián E; CROSS, R. Matthew et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 1, pp 417-424, issn 0066-4804, 8 p.Article

Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor-Positive Metastatic Breast CancerJOHNSTON, Stephen; PIPPEN, John; PRESS, Michael F et al.Journal of clinical oncology. 2009, Vol 27, Num 33, pp 5538-5546, issn 0732-183X, 9 p.Article

An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virusFOSTER, Charles B; LEHRNBECHER, Thomas; YARCHOAN, Robert et al.Blood. 2000, Vol 96, Num 7, pp 2562-2567, issn 0006-4971Article

Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessmentXIAOLEI ZHOU; CELLA, David; CAMERON, David et al.Breast cancer research and treatment. 2009, Vol 117, Num 3, pp 577-589, issn 0167-6806, 13 p.Article

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab : updated efficacy and biomarker analysesCAMERON, David; CASEY, Michelle; CHAN, Arlene et al.Breast cancer research and treatment. 2008, Vol 112, Num 3, pp 533-543, issn 0167-6806, 11 p.Article

Strong evidence for autosomal dominant inheritance of severe congenital neutropenia associated with ELA2 mutationsBOXER, Laurence A; STEIN, Steven; BUCKLEY, Danielle et al.The Journal of pediatrics. 2006, Vol 148, Num 5, pp 633-636, issn 0022-3476, 4 p.Article

Multiple intraabdominal soft-tissue masses in a man awaiting liver transplantation: A case study and discussionSTEIN, Steven; DUARTE, Paulo S; ALAVI, Abass et al.American journal of clinical oncology. 2000, Vol 23, Num 5, pp 506-508, issn 0277-3732Article

Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpuraAQUI, Nicole A; STEIN, Steven H; KONKLE, Barbara A et al.Journal of clinical apheresis (Print). 2003, Vol 18, Num 2, pp 51-54, issn 0733-2459, 4 p.Article

Lapatinib antitumor activity is not dependent upon phosphatase and tensin homologue deleted on chromosome 10 in ErbB2-overexpressing breast cancersWENLE XIA; HUSAIN, Intisar; LEIHUA LIU et al.Cancer research (Baltimore). 2007, Vol 67, Num 3, pp 1170-1175, issn 0008-5472, 6 p.Article

HLA-DQA1^*02:01 Is a Major Risk Factor for Lapatinib-Induced Hepatotoxicity in Women With Advanced Breast CancerSPRAGGS, Colin F; BUDDE, Laura R; CARDON, Lon R et al.Journal of clinical oncology. 2011, Vol 29, Num 6, pp 667-673, issn 0732-183X, 7 p.Article

Phase III, Double-Blind, Randomized Study Comparing Lapatinib Plus Paclitaxel With Placebo Plus Paclitaxel As First-Line Treatment for Metastatic Breast CancerDI LEO, Angelo; GOMEZ, Henry L; WILLIAMS, Lisa S et al.Journal of clinical oncology. 2008, Vol 26, Num 34, pp 5544-5552, issn 0732-183X, 9 p.Article

Efficacy and Safety of Lapatinib As First-Line Therapy for ErbB2-Amplified Locally Advanced or Metastatic Breast CancerGOMEZ, Henry L; DOVAL, Dinesh C; CASEY, Michelle A et al.Journal of clinical oncology. 2008, Vol 26, Num 18, pp 2999-3005, issn 0732-183X, 7 p.Article

Page / 1